Targeting lymphoid malignancies with small molecule inhibitors of pro-survival Bcl-2 proteins.

被引:0
作者
Roberts, AW
Wei, A
van Delft, MF
Mason, KD
Adams, JM
Huang, DCS
机构
[1] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia
[2] Royal Melbourne Hosp, Clin Haematol & Med Oncol, Parkville, Vic, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1486
引用
收藏
页码:428A / 428A
页数:1
相关论文
共 50 条
[21]   Small-molecule inhibitors of Bcl-2 protein [J].
Pulley, H ;
Mohammad, R .
DRUGS OF THE FUTURE, 2004, 29 (04) :369-381
[22]   The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy [J].
P N Kelly ;
A Strasser .
Cell Death & Differentiation, 2011, 18 :1414-1424
[23]   The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy [J].
Kelly, P. N. ;
Strasser, A. .
CELL DEATH AND DIFFERENTIATION, 2011, 18 (09) :1414-1424
[24]   Structure-based Drug Design Strategies in the Development of Small Molecule Inhibitors Targeting Bcl-2 Family Proteins [J].
Yin, Zhe ;
Yang, Donglin ;
Wang, Jun ;
Jiang, Yuequan .
LETTERS IN DRUG DESIGN & DISCOVERY, 2020, 17 (08) :943-953
[25]   Small-molecule inhibitors of Bcl-2 family proteins as therapeutic agents in cancer [J].
Mohammad, Ramzi ;
Giri, Anshu ;
Goustin, Anton-Scott .
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2008, 3 (01) :20-30
[26]   Bcl-2 gene rearrangements in lymphoid malignancies [J].
Crisan, D .
CLINICS IN LABORATORY MEDICINE, 1996, 16 (01) :23-&
[27]   Role of Bcl-2 Family in Lymphoid Malignancies [J].
Strasser, Andreas ;
Kelly, G. ;
Glaser, S. ;
Grabow, S. ;
Delbridge, A. ;
Adams, J. M. ;
Herold, M. .
BLOOD, 2013, 122 (21)
[28]   Targeting BCL-2 in Hematologic Malignancies [J].
Khan, Nadia ;
Kahl, Brad .
TARGETED ONCOLOGY, 2018, 13 (03) :257-267
[29]   Targeting BCL-2 in Hematologic Malignancies [J].
Nadia Khan ;
Brad Kahl .
Targeted Oncology, 2018, 13 :257-267
[30]   Small-Molecule and Peptide Inhibitors of the Pro-Survival Protein Mcl-1 [J].
Beekman, Andrew M. ;
Howell, Lesley A. .
CHEMMEDCHEM, 2016, 11 (08) :802-813